GL Ventures, the VC arm of Hillhouse Capital, led a USD147m Series D for China-based biotech company InventisBio, with participation from new investors Qiming Venture Partners, Matrix Partners China, Janchor Partners, AIHC Capital, Dyee Capital, and E Fund Capita. Existing investors Lilly Asia Ventures, Advantech Capital, OrbiMed Asia, Pudong Innotek Capital, and CMB International also participated. Read more